Bill > S0640

This bill modifies Florida's existing law regarding the retail sale of ephedrine and related compounds by introducing two new definitions: "administrator of the electronic recordkeeping system" (the entity responsible for managing an electronic system approved by the Department of Law Enforcement) and "covered entity" (a manufacturer of ephedrine or related compounds sold within or into the state). The bill expands the law's applicability to include manufacturers as covered entities, subject to specific recordkeeping requirements, and adjusts criminal penalties for violations. Specifically, the bill maintains existing penalty structures for violations, which escalate from a second-degree misdemeanor for a first offense to a third-degree felony for third or subsequent offenses. The bill is contingent upon the adoption of another related piece of legislation (SB 642) and is scheduled to take effect on July 1, 2025, but only if that companion bill is also enacted. Ephedrine and related compounds are defined as ephedrine, pseudoephedrine, phenylpropanolamine, and their various salt and isomer forms, which are often used in cold medications but can also be used in the illicit production of methamphetamine.

https://www.flsenate.gov/Session/Bill/2025/640